Search hospitals > Texas > Dallas
Metroplex Clinical Research Center
Claim this profileDallas, Texas 75231
Global Leader in Arthritis
Global Leader in Rheumatoid Arthritis
Conducts research for Systemic Lupus Erythematosus
Conducts research for Osteoarthritis
Conducts research for Lupus
97 reported clinical trials
2 medical researchers
Summary
Metroplex Clinical Research Center is a medical facility located in Dallas, Texas. This center is recognized for care of Arthritis, Rheumatoid Arthritis, Systemic Lupus Erythematosus, Osteoarthritis, Lupus and other specialties. Metroplex Clinical Research Center is involved with conducting 97 clinical trials across 43 conditions. There are 2 research doctors associated with this hospital, such as Roy Fleischmann and STANLEY COHEN.Area of expertise
1Arthritis
Global LeaderRheumatoid factor positive
Anti-cyclic citrullinated peptide autoantibodies positive
2Rheumatoid Arthritis
Global LeaderRheumatoid factor positive
Anti-cyclic citrullinated peptide autoantibodies positive
Top PIs
Roy FleischmannMetroplex Clinical Research Center2 years of reported clinical research
Studies Arthritis
Studies Rheumatoid Arthritis
8 reported clinical trials
14 drugs studied
STANLEY COHENMetroplex Clinical Research Center1 year of reported clinical research
Studies Arthritis
Studies Rheumatoid Arthritis
7 reported clinical trials
7 drugs studied
Clinical Trials running at Metroplex Clinical Research Center
Rheumatoid Arthritis
Arthritis
Systemic Lupus Erythematosus
Lupus
Cutaneous Lupus Erythematosus
Systemic Sclerosis
Osteoarthritis
Psoriatic Arthritis
Systemic Scleroderma
Scleroderma
Baricitinib
for Rheumatoid Arthritis
This trial compares the safety of two treatments for rheumatoid arthritis, focusing on the risk of blood clots. One treatment is baricitinib, an oral medication used for moderate to severe cases.
Recruiting3 awards Phase 43 criteria
Splenic Stimulation
for Rheumatoid Arthritis
This study will evaluate the safety, tolerability, and effects of stimulating the splenic neurovascular bundle (NVB) with the Galvani System, which consists of a lead, implantable pulse generator, external components and accessories. The study will consist of 4 study periods, including a Randomized Control Trial period (Period 1), an Open Label period (Period 2), a Treat-to-target period (Period 3), and a Long-term Follow-up period (Period 4). Participants eligible for implant will have active rheumatoid arthritis (RA) and have an inadequate response or intolerance to at least two biologic Disease Modifying Anti-Rheumatic Drugs (DMARDs) or JAK inhibitors (JAKis). A sufficient number of participants will be enrolled so that approximately 28 participants will undergo device implantation.
Recruiting2 awards N/A3 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Metroplex Clinical Research Center?
Metroplex Clinical Research Center is a medical facility located in Dallas, Texas. This center is recognized for care of Arthritis, Rheumatoid Arthritis, Systemic Lupus Erythematosus, Osteoarthritis, Lupus and other specialties. Metroplex Clinical Research Center is involved with conducting 97 clinical trials across 43 conditions. There are 2 research doctors associated with this hospital, such as Roy Fleischmann and STANLEY COHEN.